Rifamycin SV-MMX 600 mg t.i.d.
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rifamycin SV-MMX 600 mg t.i.d., covering 2017-07-26 to 2017-07-26. Get the full timeline:
Most recent: Clinical Trial Update: Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis [Phase 2]